Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.36232 | 14 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.34113 | 14 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.34263 | 14 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.29551 | 14 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.28939 | 13 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.39772 | 14 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.36581 | 14 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.31868 | 13 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.31344 | 14 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.33232 | 14 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.32515 | 14 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.31671 | 14 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.33145 | 13 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.33278 | 14 |